According to Caris Life Sciences's latest financial reports the company's current EPS (TTM) is -7,44ย โฌ. In 2024 the company made an earnings per share (EPS) of -2,33ย โฌ a decrease over its 2023 EPS that were of -1,56ย โฌ.